49 Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Sell
2,413
-100
-4% -$10.4K 0.01% 210
2026
Q2
$245K Hold
2,513
– – 0.02% 196
2026
Q1
$211K Buy
+2,513
New +$146K 0.02% 185

Other funds holding DNTH

49 Wealth Management's DNTH Position: Q3 2026 in Review

49 Wealth Management reduced its Dianthus Therapeutics (DNTH) stake by 4% in Q3 2026, selling an estimated $10.4K and leaving 2,413 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #210.

49 Wealth Management first reported a position in DNTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $245K in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • 49 Wealth Management held 2,413 shares of Dianthus Therapeutics worth $212K as of Q3 2026.
  • 49 Wealth Management sold 100 Dianthus Therapeutics shares in Q3 2026, an estimated $10.4K.
  • Dianthus Therapeutics made up 0.01% of 49 Wealth Management's portfolio in Q3 2026, its #210 holding.
  • 49 Wealth Management first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • 49 Wealth Management's Dianthus Therapeutics position peaked at $245K in Q2 2026.
  • 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on 49 Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.